Do Management Consultants Even Need Sales Tax Software

Advisory fees, whether billed as a fixed project fee, a monthly retainer, or hourly time, are commonly treated as an exempt professional service in most states, the same way legal or accounting advice is. Deliverables like a strategy deck, a market analysis, or a set of recommendations do not usually change that treatment just because they are a tangible document, since states generally look at what you were paid for, the advice, not the paper it arrives on.

Reimbursed travel and out-of-pocket expenses passed through to a client at cost are also typically outside sales tax, though how you document the pass-through matters if a state ever asks.

If your firm has built a proprietary assessment tool, a benchmarking dashboard, or a diagnostic platform that clients access on a subscription basis separate from the advisory engagement itself, that piece behaves like software revenue and can be taxable in states that tax SaaS. The same is true if you license a framework or toolkit for a flat fee rather than delivering it as part of billable advisory time.

A firm running a clean advisory-only model with zero software or licensing revenue may not need either Anrok or Avalara at all. A firm that has quietly grown a second, product-like revenue line is the one that actually needs this decision.

Speaking and training revenue can also shift the picture. A workshop or training session delivered live is usually treated the same as advisory time, but a recorded course or a self-serve learning portal sold on its own starts to look like a digital product, which a growing number of states do tax. If your firm has started packaging what used to be one-on-one advisory work into something a client can buy and access without you in the room, that packaging is the signal to watch.

If your assessment tool or diagnostic platform bills through a subscription tool like Stripe Billing, Anrok applies SaaS-style taxability logic to that fee specifically and tracks nexus as that piece of revenue grows, without touching your advisory invoices at all. This keeps the two revenue lines cleanly separated, which matters when only one of them is actually a taxable event.

A larger consulting firm running multiple entities, billing through an ERP, or operating in several countries fits Avalara's broader coverage more comfortably, particularly once international VAT or GST questions enter the picture alongside any US sales tax exposure from a licensed tool.

Median annual pay for a general operations manager is $105,770, reaching past $167,280 at the 75th percentile¹, and firms at that scale typically already have someone in that role who needs tax handled without becoming their part-time job.

List every distinct revenue line on your income statement for the last year. For each one, ask whether it is advisory time, a licensed tool or platform, or something else entirely. If everything is advisory time, put this decision on hold and revisit it if that changes. If a licensed tool or platform shows up as a real, growing number, that is the line worth running through either Anrok or Avalara, not your advisory fees.

G&A costs commonly run as a meaningful share of revenue at firms this size², and buying tax software for revenue that was never taxable in the first place is money spent solving a problem you do not have.

Do this review at least once a year, not just once. A firm that launches a diagnostic tool as a small pilot this year can easily have it become a quarter of revenue two years later, and the point at which that shift matters for sales tax purposes is rarely the point at which someone remembers to check.

Run this check before buying anything:

1. List every distinct revenue line on your income statement for the last year.
2. Label each line as advisory time, a licensed tool or platform, or something else entirely.
3. If everything is advisory time, put the software decision on hold, since neither tool matters much yet.
4. If a licensed tool or platform bills separately, track that revenue on its own and confirm its treatment state by state.
5. Revisit the decision when a second revenue line, such as a subscription assessment tool, starts to grow.